{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:50:01Z","timestamp":1781027401726,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Pharmacy Association Health Education Bursary UK"},{"name":"Harold and Marjorie Moss Charitable Trust UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11096-019-00790-x","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T03:17:49Z","timestamp":1550200669000},"page":"470-477","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Community pharmacists\u2019 role in preventing opioid substitution therapy-related deaths: a qualitative investigation into current UK practice"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8954-9782","authenticated-orcid":false,"given":"Ramesh","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"790_CR1","unstructured":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group. Drug misuse and dependence: UK guidelines on clinical management. London: Department of Health; 2017. p. 83, 106. Available at \n                    https:\/\/www.gov.uk\/government\/publications\/drug-misuse-and-dependence-uk-guidelines-on-clinical-management\n                    \n                  . Accessed 7 Mar 2018."},{"issue":"9","key":"790_CR2","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.3310\/hta11090","volume":"11","author":"M Connock","year":"2007","unstructured":"Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor R, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11(9):ix.","journal-title":"Health Technol Assess"},{"key":"790_CR3","doi-asserted-by":"publisher","first-page":"c4851","DOI":"10.1136\/bmj.c4851","volume":"341","author":"J Strang","year":"2010","unstructured":"Strang J, Hall W, Hickman M, Bird SM. Impact of supervision of methadone consumption on deaths related to methadone overdose (1993\u20132008): analyses using OD4 index in England and Scotland. BMJ. 2010;341:c4851. \n                    https:\/\/doi.org\/10.1136\/bmj.c4851\n                    \n                  .","journal-title":"BMJ."},{"key":"790_CR4","unstructured":"CPPE Substance use and misuse modules 1\u20134, \n                    https:\/\/www.cppe.ac.uk\/programmes\/l\/substance2-e-01\n                    \n                  . Accessed 19 Sept 2018."},{"key":"790_CR5","unstructured":"Office for national statistics. Deaths related to drug poisonin in England and wales: 2015 registrations. Office for national statistics 2016. Available at \n                    https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2016registrations\n                    \n                  . Accessed 7 Mar 2018."},{"key":"790_CR6","unstructured":"National records of Scotland. Drug-related deaths in Scotland in 2015. National Records of Scotland 2016. Available at \n                    https:\/\/www.nrscotland.gov.uk\/statistics-and-data\/statistics\/statistics-by-theme\/vital-events\/deaths\/drug-related-deaths-in-scotland\/2016\/list-of-tables-and-figures\n                    \n                  . Accessed 7 Mar 2018."},{"key":"790_CR7","unstructured":"Northern Ireland Statistics and Research Agency. Drug Related and Drug Misuse Deaths 2006-2015. Northern Ireland Statistics and Research Agency 2017. Available at \n                    https:\/\/www.nisra.gov.uk\/publications\/drug-related-and-drug-misuse-deaths-2006-2015\n                    \n                  . Accessed 1 Feb 2017."},{"issue":"11","key":"790_CR8","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1111\/j.1360-0443.2007.02016.x","volume":"102","author":"J Sheridan","year":"2007","unstructured":"Sheridan J, Manning V, Ridge G, Mayet S, Strang J. Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995\u20132005. Addiction. 2007;102(11):1824\u201330.","journal-title":"Addiction"},{"issue":"6","key":"790_CR9","first-page":"639","volume":"32","author":"H Robertson","year":"2015","unstructured":"Robertson H, Bond C, Matheson C. The evolution of pharmaceutical care for drug misusers. Fam Pract. 2015;32(6):639\u201345.","journal-title":"Fam Pract"},{"issue":"8","key":"790_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1111\/add.12971","volume":"110","author":"M White","year":"2015","unstructured":"White M, Burton R, Darke S, Eastwood B, Knight J, Millar T, et al. Fatal opioid poisoning: a counterfactual model to estimate the preventive effect of treatment for opioid use disorder in England. Addiction. 2015;110(8):1321\u20139.","journal-title":"Addiction"},{"issue":"1","key":"790_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/add.13087","volume":"111","author":"G Cousins","year":"2015","unstructured":"Cousins G, Boland F, Courtney B, Barry J, Lyons S, Fahey T. Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study. Addiction. 2015;111(1):73\u201382.","journal-title":"Addiction"},{"key":"790_CR12","unstructured":"Advisory Council on the Misuse of Drugs. How can opioid substitution therapy (and drug treatment and recovery systems) be optimised to maximise recovery outcomes for service users? London: Advisory Council on the Misuse of Drugs 2015. p.15\u201318. Available at \n                    https:\/\/www.gov.uk\/government\/publications\/how-can-opioid-substitution-therapy-be-optimised-to-maximise-recovery-outcomes-for-service-users\n                    \n                  . Accessed 7 Mar 2018."},{"key":"790_CR13","unstructured":"Public health England. Understanding and preventing drug-related deaths. London: Public Health England 2016. p.16\u201318. Available at \n                    https:\/\/www.gov.uk\/government\/publications\/preventing-drug-related-deaths\n                    \n                  . Accessed 7 Mar 2018."},{"key":"790_CR14","unstructured":"Hassell K. (2012). GPh C Register Analysis 2011. [online] Available at: \n                    https:\/\/www.pharmacyregulation.org\/sites\/default\/files\/Analysis%20of%20GPhC%20Pharmacist%20Register%202011.pdf\n                    \n                  . Accessed 1 Feb 2017."},{"key":"790_CR15","unstructured":"Smith J, Larkin M, Flowers P. Interpretative phenomenological analysis. Los Angeles: SAGE; 2009."},{"key":"790_CR16","unstructured":"Clinical guidelines on drug misuse and dependence update 2017 independent expert working group. Drug misuse and dependence: UK guidelines on clinical management. London: Department of health 2017. p. 87,98. Available at \n                    https:\/\/www.gov.uk\/government\/publications\/drug-misuse-and-dependence-uk-guidelines-on-clinical-management\n                    \n                  . Accessed 7 Mar 2018."},{"key":"790_CR17","unstructured":"Department of Health. The government response to the advisory council on the misuse of drugs report into drug related deaths. London: Department of Health 2001. p. 21. Available at \n                    http:\/\/webarchive.nationalarchives.gov.uk\/20130103041706\/http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/@dh\/@en\/documents\/digitalasset\/dh_4060881.pdf\n                    \n                  . Accessed 7 Mar 2018."},{"issue":"7","key":"790_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5688\/ajpe777147","volume":"77","author":"P Rutter","year":"2013","unstructured":"Rutter P, Taylor D, Branford D. Mental health curricula at schools of pharmacy in the United Kingdom and recent graduates\u2019 readiness to practice. Am J Pharm Educ. 2013;77(7):147.","journal-title":"Am J Pharm Educ"},{"issue":"2","key":"790_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1360-0443.2009.02774.x","volume":"105","author":"A Winstock","year":"2009","unstructured":"Winstock A, Lea T, Sheridan J. Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Austrilia. Addiction. 2009;105(2):335\u201342. \n                    https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02774.x\n                    \n                  .","journal-title":"Addiction"},{"key":"790_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.sapharm.2012.01.001","volume":"8","author":"A Irwin","year":"2012","unstructured":"Irwin A, Laing C, Mearns K. Dealing with aggressive methadone patients in community pharmacy: a critical incident study. Res Soc Adm Pharm. 2012;8:542\u201351.","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"790_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3351\/ppp.0006.0001.0004","volume":"6","author":"M Monaghan","year":"2012","unstructured":"Monaghan M. The recent evolution of UK drug strategies: from maintenance to behaviour change? People Place Policy Online. 2012;6(1):29\u201340.","journal-title":"People Place Policy Online"},{"issue":"1","key":"790_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0022042612466614","volume":"43","author":"K Duke","year":"2013","unstructured":"Duke K. From crime to recovery. J Drug Issues. 2013;43(1):39\u201355.","journal-title":"J Drug Issues"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-019-00790-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-019-00790-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:05:14Z","timestamp":1581707114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-019-00790-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1007\/s11096-019-00790-x","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,15]]},"assertion":[{"value":"22 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}